Therefore, we speculate that promoting mTOR-mediated macroautophagy and PINK1/Parkin signaling-mediated mitophagy is a therapeutic mechanism that reduces renal inflammation, fibrosis, and injury in DN kidneys. This evidence concerns the gene PRKN and liver dysplastic nodule.